13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001920938
申报总市值
US$27.0亿
US$27.0亿
81 檔
26.9%
根据最新整理的 13F 季度数据集，Braidwell LP 于 Q3 2024 结束时的管理资产规模为 US$27.0亿。该机构在本季度申报了 81 档美股持仓，呈现出该时期的主要投资地图。
Braidwell LP 在 Q3 2024 进行了结构性的板块轮动与仓位换股。在开立 16 个全新仓位及加仓 26 档持股的同时，亦同步清仓 10 档并减仓 24 档标的。
在资产配置集中度方面，Braidwell LP 的前 5 大核心持股（包含 GH 0 11-15-27, BBIO 2.5 03-15-27, NVCR 0 11-01-25 等）合计占整体申报市值的 26.9%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 0 11-15-27债券 | Guardant Health Inc | 债券 | 6.12% | — | — | |
| 2 | BBIO 2.5 03-15-27债券 | Bridgebio Pharma Inc | 债券 | 4.13% | — | — | |
| 3 | NVCR 0 11-01-25债券 | Novocure LTD | 债券 | 3.78% | — | — | |
| 4 | CGON | Cg Oncology Inc | 股票-其他 | 3.39% | -2.22% | EXIT | |
| 5 | GMED 0.375 03-15-25债券 | Nuvasive Inc | 债券 | 3.17% | — | — | |
| 6 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.02% | -0.07% | +5.73% | |
| 7 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 3.00% | -0.77% | +20.90% | |
| 8 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 2.75% | -2.44% | — | |
| 9 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.74% | -1.34% | EXIT | |
| 10 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 2.55% | — | +410.82% | |
| 11 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | 债券 | 2.34% | — | +3.34% | |
| 12 | DXCM 0.375 05-15-28债券 | Dexcom Inc | 债券 | 2.33% | — | +12.09% | |
| 13 | ALGN | Align Technology Inc | 股票-医疗保健 | 2.25% | — | +13.25% | |
| 14 | GH | Guardant Health Inc | 股票-医疗保健 | 2.17% | -0.72% | +19.02% | |
| 15 | PODD 0.375 09-01-26债券 | Insulet Corporation | 债券 | 2.17% | — | -6.18% | |
| 16 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 2.13% | — | -7.68% | |
| 17 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 2.08% | — | +4.52% | |
| 18 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 2.05% | -0.01% | +40.63% | |
| 19 | PEN | Penumbra Inc | 股票-医疗保健 | 1.99% | -1.15% | EXIT | |
| 20 | DXCM 0.25 11-15-25债券 | Dexcom Inc | 债券 | 1.99% | — | — | |
| 21 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 1.97% | +1.04% | -7.43% | |
| 22 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 1.92% | — | +60.54% | |
| 23 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.83% | +1.32% | -12.91% | |
| 24 | RGEN | Repligen CORP | 股票-医疗保健 | 1.67% | +0.70% | +22.65% | |
| 25 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 1.65% | +0.48% | +48.67% | |
| 26 | TVTX 2.5 09-15-25债券 | Travere Therapeutics Inc | 债券 | 1.52% | — | — | |
| 27 | ATEC 0.75 08-01-26债券 | Alphatec Holdings Inc | 债券 | 1.49% | — | — | |
| 28 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 1.49% | -1.46% | -42.06% | |
| 29 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 1.48% | +0.53% | — | |
| 30 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.43% | -0.05% | -37.04% | |
| 31 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 1.31% | — | +352.26% | |
| 32 | BBIO 2.25 02-01-29债券 | Bridgebio Pharma Inc | 债券 | 1.28% | — | -18.29% | |
| 33 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.27% | -0.16% | -9.15% | |
| 34 | ✓ | Avadel Pharmaceuticals PLC ADR | 股票-其他 | 1.26% | — | +16.91% | |
| 35 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 1.20% | — | — | |
| 36 | KROS | Keros Therapeutics Inc | 股票-其他 | 1.16% | — | -28.00% | |
| 37 | GKOS | Glaukos CORP | 股票-医疗保健 | 1.15% | +0.32% | -37.25% | |
| 38 | MDGL | Madrigal Pharmaceuticals Inc | 股票-医疗保健 | 1.11% | — | — | |
| 39 | PCVX | Vaxcyte Inc | 股票-其他 | 0.96% | — | -63.19% | |
| 40 | REPL | Replimune Group Inc | 股票-其他 | 0.95% | — | +203.03% | |
| 41 | ARVN | Arvinas Inc | 股票-其他 | 0.90% | — | +148.34% | |
| 42 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 0.87% | +0.20% | +57.39% | |
| 43 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.85% | +0.20% | — | |
| 44 | DXCM | Dexcom Inc | 股票-医疗保健 | 0.84% | — | — | |
| 45 | BNTX | Biontech Se-adr | 股票-其他 | 0.83% | — | — | |
| 46 | FNAUSD | Paragon 28 Inc | 股票-其他 | 0.78% | — | -0.36% | |
| 47 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.70% | — | +16.38% | |
| 48 | ATEC | Alphatec Holdings Inc | 股票-其他 | 0.64% | +1.30% | +84.11% | |
| 49 | HROW | Harrow Inc | 股票-其他 | 0.56% | -0.18% | EXIT | |
| 50 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 0.56% | — | +567.62% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | APLSUSD | Apellis Pharmaceuticals Inc | +1.8% | +410.82% | 加仓 |
| 2 | EWTX | Edgewise Therapeutics Inc | +1.5% | NEW | 新建仓 |
| 3 | BCAX | Bicara Therapeutics Inc | +1.2% | NEW | 新建仓 |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | +1.1% | NEW | 新建仓 |
| 5 | SRPT | Sarepta Therapeutics Inc | +0.9% | +352.26% | 加仓 |
| 6 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.8% | +40.63% | 加仓 |
| 7 | DXCM | Dexcom Inc | +0.8% | NEW | 新建仓 |
| 8 | BNTX | Biontech Se-adr | +0.8% | NEW | 新建仓 |
| 9 | PEN | Penumbra Inc | +0.8% | +70.01% | 加仓 |
| 10 | REPL | Replimune Group Inc | +0.7% | +203.03% | 加仓 |
| 11 | DAWNGBX | Day One Biopharmaceuticals I | +0.6% | +60.54% | 加仓 |
| 12 | AMPH 2 03-15-29债券 | Amphastar Pharmaceutical | +0.6% | NEW | 新建仓 |
| 13 | ✓ | Immatics NV | +0.5% | NEW | 新建仓 |
| 14 | ARVN | Arvinas Inc | +0.5% | +148.34% | 加仓 |
| 15 | CGEM | Cullinan Therapeutics Inc | +0.5% | +567.62% | 加仓 |
| 16 | BSX | Boston Scientific CORP | +0.5% | NEW | 新建仓 |
| 17 | RGEN | Repligen CORP | +0.4% | +22.65% | 加仓 |
| 18 | HROW | Harrow Inc | +0.4% | +47.93% | 加仓 |
| 19 | ORKA | Oruka Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 20 | ✓ | Zura Bio LTD | +0.3% | NEW | 新建仓 |
| 21 | PODD | Insulet CORP | +0.3% | NEW | 新建仓 |
| 22 | XNCR | Xencor Inc | +0.3% | NEW | 新建仓 |
| 23 | JSPR | Jasper Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 24 | KRYS | Krystal Biotech Inc | +0.3% | +57.39% | 加仓 |
| 25 | VKTX | Viking Therapeutics Inc | +0.2% | +4.52% | 加仓 |
| 26 | OCUL | Ocular Therapeutix Inc | +0.2% | +36.26% | 加仓 |
| 27 | ALGN | Align Technology Inc | +0.2% | +13.25% | 加仓 |
| 28 | FDMT | 4d Molecular Therapeutics In | +0.1% | +231.69% | 加仓 |
| 29 | CGON | Cg Oncology Inc | +0.1% | -4.19% | 减仓 |
| 30 | FULC | Fulcrum Therapeutics Inc | +0.1% | NEW | 新建仓 |
| 31 | CELC | Celcuity Inc | +0.1% | +71.16% | 加仓 |
| 32 | ✓ | Verve Therapeutics Inc | +0.1% | NEW | 新建仓 |
| 33 | RLAY | Relay Therapeutics Inc | +0.1% | +16.38% | 加仓 |
| 34 | DNTH | Dianthus Therapeutics Inc | +0.1% | +34.57% | 加仓 |
| 35 | ✓ | Hillevax Inc | +0.1% | NEW | 新建仓 |
| 36 | LUNG | Pulmonx CORP | 0% | — | 不变 |
| 37 | TVTX 2.5 09-15-25债券 | Travere Therapeutics Inc | 0% | — | 不变 |
| 38 | CSTL | Castle Biosciences Inc | 0% | -20.21% | 减仓 |
| 39 | SYRE | Spyre Therapeutics Inc | 0% | -12.91% | 减仓 |
| 40 | ✓ | Avadel Pharmaceuticals PLC ADR | 0% | +16.91% | 加仓 |
| 41 | CUTR 4 06-01-29债券 | Cutera Inc | 0% | — | 不变 |
| 42 | ✓ | Dbv Technologies S A | 0% | -33.24% | 减仓 |
| 43 | HAE 0 03-01-26债券 | Haemonetics CORP | 0% | — | 不变 |
| 44 | ETNBGBP | 89bio Inc | 0% | EXIT | 清仓 |
| 45 | BBIO | Bridgebio Pharma Inc | -0.1% | -13.65% | 减仓 |
| 46 | CUTR 2.25 06-01-28债券 | Cutera Inc | -0.1% | — | 不变 |
| 47 | ALEC | Alector Inc | -0.1% | -9.34% | 减仓 |
| 48 | MRVI | Maravai Lifesciences Hldgs-a | -0.1% | -7.43% | 减仓 |
| 49 | OMGBP | Outset Medical Inc | -0.1% | EXIT | 清仓 |
| 50 | ATEC | Alphatec Holdings Inc | -0.1% | +84.11% | 加仓 |
根据 SEC 官方 Form 13F 申报备案，Braidwell LP 在 Q3 2024 季度的美股持仓总市值约为 US$27.0亿，共申报了 81 个公开持股仓位。
在 Q3 2024 季度，Braidwell LP 按市值排列的前三大核心持股分别为：GH 0 11-15-27 (6.1%)、BBIO 2.5 03-15-27 (4.1%)、NVCR 0 11-01-25 (3.8%)。其中最大持股仓位 GH 0 11-15-27 占据整体投资组合约 6.1% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
EWTX
市值: US$5226.7万
本季最大获利了结 / 清仓标的
SRPT 1.25 09-15-27
前期市值: US$5551.2万
在 Q3 2024 季度中，Braidwell LP 共进行了 76 项持仓异动，包含新建仓 16 个仓位、加仓 26 个仓位、减仓 24 个仓位以及清仓 10 个仓位。 其中最大新建仓标的为 EWTX。 本季清仓仓位包含 SRPT 1.25 09-15-27。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。